LYON, France--(BUSINESS WIRE)--Platine Pharma Services SAS (PPS), a majority owned subsidiary of ABL, Inc., is a preferred partner with Quanterix Corporation, providing new ultrasensitive assays using the single molecule measurement digital platform, Simoa. Quanterix, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, has selected ABL, the first CRO in Europe with the ability to develop new assays and validate methods for research or clinical testing to detect femtomolar levels of analytes in preclinical or clinical samples.
